Tamarack Advisers, LP Merck & Co., Inc. Transaction History

Tamarack Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4.23 Million - $4.75 Million	-50,000 Reduced 66.67%	25,000 $2.15 Million
Q2 2022 Aug 16, 2022	SELL	$83.49 - $94.64 $6.68 Million - $7.57 Million	-80,000 Reduced 51.61%	75,000 $6.84 Million
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $6.25 Million - $7 Million	85,000 Added 121.43%	155,000 $12.7 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $5.06 Million - $6.34 Million	70,000 New	70,000 $5.37 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $6.34 Million - $7.21 Million	-90,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $5.7 Million - $7.9 Million	90,000 New	90,000 $6.93 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.